Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H8O4 |
Molecular Weight | 132.1146 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CCCC(O)=O
InChI
InChIKey=JFCQEDHGNNZCLN-UHFFFAOYSA-N
InChI=1S/C5H8O4/c6-4(7)2-1-3-5(8)9/h1-3H2,(H,6,7)(H,8,9)
Molecular Formula | C5H8O4 |
Molecular Weight | 132.1146 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
A Korean girl with alpha-aminoadipic and alpha-ketoadipic aciduria accompanied with elevation of 2-hydroxyglutarate and glutarate. | 2001 Aug |
|
Evaporation rates and vapor pressures of individual aerosol species formed in the atmospheric oxidation of alpha- and beta-pinene. | 2001 Aug 15 |
|
Biochemical and molecular diagnosis of glutaric aciduria type 1 in a black South African male child: case report. | 2001 Dec |
|
Effect of type and level of dietary fat on rumen fermentation and performance of dairy cows fed corn silage-based diets. | 2001 Dec |
|
Prenatal diagnosis of glutaric acidemias. | 2001 Dec |
|
Identification in Saccharomyces cerevisiae of two isoforms of a novel mitochondrial transporter for 2-oxoadipate and 2-oxoglutarate. | 2001 Jan 19 |
|
[Bilateral hypodensity of the basal ganglia. Clinico-evolutionary correlation in children]. | 2001 Jul 16-31 |
|
The first case of 4-hydroxybutyric aciduria in Japan. | 2001 Mar |
|
IGF-1 and bFGF reduce glutaric acid and 3-hydroxyglutaric acid toxicity in striatal cultures. | 2001 Nov |
|
Cationic amino acids involved in dicarboxylate binding of the flounder renal organic anion transporter. | 2001 Oct |
|
Binding of the glutamate carboxypeptidase II (NAALADase) inhibitor 2-PMPA to rat brain membranes. | 2001 Sep 14 |
|
Molecular characterization of the renal organic anion transporter 1. | 2002 |
|
[Glutaric aciduria type 2]. | 2002 Apr |
|
[Electron transfer flavoprotein in mitochondria]. | 2002 Apr |
|
Isomer separation of hyperbranched polyesteramides with gas-phase H/D exchange and a novel MS(n) approach: DoDIP. | 2002 Aug |
|
Nanomolar small molecule inhibitors for alphav(beta)6, alphav(beta)5, and alphav(beta)3 integrins. | 2002 Feb 28 |
|
Outcome of the first 3-years of a DNA-based neonatal screening program for glutaric acidemia type 1 in Manitoba and northwestern Ontario, Canada. | 2002 Jan |
|
Design, synthesis and pharmacological evaluation of novel pyrazolo[3,4-b]thieno[2,3-d]pyridine acid derivatives: a new class of anti-inflammatory and anti-platelet agents. | 2002 Jan 7 |
|
Isolation, characterization and differential gene expression of multispecific organic anion transporter 2 in mice. | 2002 Jul |
|
The effects of organic species on the hygroscopic behaviors of inorganic aerosols. | 2002 Jun 1 |
|
Novel cyclic templates of alpha-MSH give highly selective and potent antagonists/agonists for human melanocortin-3/4 receptors. | 2002 Jun 6 |
|
Effects of restricted and ad libitum intake of diets containing wheat middlings on site and extent of digestion in steers. | 2002 Mar |
|
Prediction of ruminal pH from pasture-based diets. | 2002 May |
|
Glutaric aciduria type I diagnosed after poliovirus immunization: magnetic resonance findings. | 2002 May |
|
Cancer chemopreventive effect of quassinoid derivatives. Introduction of side chain to shinjulactone C for enhancement of inhibitory effect on Epstein-Barr virus activation. | 2002 Nov 8 |
|
Glutaric aciduria type III: a distinctive non-disease? | 2002 Oct |
|
Effects of Saccharomyces cerevisiae culture and Saccharomyces cerevisiae live cells on in vitro mixed ruminal microorganism fermentation. | 2002 Oct |
|
Antitumor activities of conjugates of mitomycin C with estradiol benzoate and estradiol via glutaric acid in suspension dosage form. | 2002 Oct |
|
Late-onset form of beta-electron transfer flavoprotein deficiency. | 2003 Apr |
|
Adult onset glutaric aciduria type I presenting with a leukoencephalopathy. | 2003 Apr 22 |
|
Intraruminal propionate supplementation modifies hindlimb energy metabolism without changing the splanchnic release of glucose in growing lambs. | 2003 Jan |
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:46:02 GMT 2025
by
admin
on
Mon Mar 31 17:46:02 GMT 2025
|
Record UNII |
H849F7N00B
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
27301-1
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
||
|
LOINC |
82504-2
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
||
|
LOINC |
54278-7
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
||
|
LOINC |
13748-9
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
||
|
LOINC |
35133-8
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
||
|
LOINC |
30474-1
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
||
|
LOINC |
25104-1
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
||
|
LOINC |
44364-8
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
||
|
LOINC |
44363-0
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
H849F7N00B
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
PRIMARY | |||
|
110-94-1
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
PRIMARY | |||
|
GLUTARIC ACID
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
PRIMARY | |||
|
C035736
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
PRIMARY | |||
|
DB03553
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
PRIMARY | |||
|
203-817-2
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
PRIMARY | |||
|
5542
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
PRIMARY | |||
|
m5779
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
PRIMARY | Merck Index | ||
|
743
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
PRIMARY | |||
|
DTXSID2021654
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
PRIMARY | |||
|
9238
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
PRIMARY | |||
|
1943799
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
PRIMARY | |||
|
17859
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
PRIMARY | |||
|
H849F7N00B
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
PRIMARY | |||
|
30921
Created by
admin on Mon Mar 31 17:46:02 GMT 2025 , Edited by admin on Mon Mar 31 17:46:02 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|